Changes in self-image after pectus carinatum brace treatment

Orrick, Beth A.; Pierce, Amy L.; McElroy, Susan F.

doi:10.1016/j.jpedsurg.2021.12.002

Cited by 6 publications

(1 citation statement)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is the second most common, probably inherited deformity of the anterior chest wall, occurring mostly in males, with a male/female ratio of 4:1 [1]. This deformity has been referred to as "undertreated chest wall deformity" due to infrequent referrals from primary care practitioners and probable underestimation of its frequency [2,3]. PC rarely causes cardiopulmonary symptoms, but mostly adolescent patients experience shame and embarrassment resulting in low self-confidence and therefore seeking treatment [4,5].…”

Section: Introductionmentioning

confidence: 99%

Bracing of Pectus Carinatum in Children: Current Practices

Omanik,

Sesia,

Kozlikova

et al. 2024

Children

View full text Add to dashboard Cite

Background: Although effective, compressive orthotic bracing (COB) in children with pectus carinatum is still not standardized. This study has aimed to analyze current practices amongst members of the Chest Wall International Group (CWIG). Methods: A web-based questionnaire was mailed to all CWIG members at 208 departments. It included 30 questions regarding diagnostic work-up, age for COB indication, type of COB used, daily wearing time, treatment duration, complications, and recurrence rate. Results: Members from 44 departments have responded (institutional response rate 21.2%). A total of 93% consider COB as the first-line treatment for PC. A conventional COB (CC) is used in 59%, and the dynamic compression system (FMF) in 41%. The overall compliance rate is >80%. A total of 67% of responders consider COB to be indicated in patients <10 years. The actual wearing time is significantly shorter than the physician-recommended time (p < 0.01). FMF patients experience a significantly faster response than CC patients (p < 0.01). No recurrence of PC has been noted in 34%; recurrence rates of 10–30% have been noted in 61%. Conclusions: COB is the first-line treatment for PC with a high compliance rate. During puberty, the recurrence rate is high. Treatment standardization and follow-up until the end of puberty are recommended to enhance COB effectiveness.

show abstract